Blog - Biognosys

Blog

Featured article

Affinity-Based Platforms and Unbiased Mass Spectrometry Combined for Enhanced Biomarker Discovery

Plasma biomarker discovery sits at the heart of precision medicine, drug development, and translational research. Yet despite decades of innovation, discovering robust, clinically actionable plasma biomarkers remains one of the most difficult challenges in proteomics.

READ MORE
April 2026
Affinity-Based Platforms and Unbiased Mass Spectrometry Combined for Enhanced Biomarker Discovery

Plasma biomarker discovery sits at the heart of precision medicine, drug development, and translational research.

Read more
April 2026
Beyond the Numbers: Why Targeted Proteomics Matters

Over the last decade, mass spectrometry–based proteomics has been on a clear mission: go deeper and go faster. 

Read more
January 2026
Immunopeptidomics Data Analysis: Challenges, Advances, and Applications

As immunotherapies become increasingly sophisticated, researchers need reliable ways to understand how drugs influence antigen presentation and immune recognition.

Read more
January 2026
Unlocking Biological Insight with Biognosys Software: A 2025 Publication Overview

This blog explores how the Biognosys software ecosystem transforms complex proteomics data into confident biological discovery.

Read more
December 2025
Pushing the Limits of Proteomics with Optimized Diagonal-PASEF and Spectronaut®

Proteomics researchers are gaining a powerful new ally in their quest for deeper, faster, and more precise protein analysis. Recent collaborative work by Biognosys Group and Bruker [...]

Read more
October 2025
How Can Library-Free directDIA Improve Immunopeptidomics with Spectronaut 20?

For researchers in immunopeptidomics, the ability to capture a complete picture of the peptides presented by MHC molecules is central to understanding immune function and advancing [...]

Read more
Load More

Contact